Silexion Therapeutics Ltd. logo

SLXNSilexion Therapeutics Ltd.

SLXN Stock Price, Valuation & Chart | Silexion Therapeutics Ltd.

Compare

SLXN Historical price chart

SLXN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization147.15K
PE Ratio-0.01
EPS-39.55
Trading Volume179.94K
Today's High/Low0.39/0.35
Dividend Yield0.00
52 Week High/Low77.7/0.35
Shares Outstanding419.00K
SLXN Financial Statement
SLXN Analyst ratings
SLXN Analysis & performance metrics

SLXN Company profile

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid…

SLXN Management team

Management
Mitchell Shirvan M.B.A., Ph.D.
Chief Scientific & Development Officer
Mirit Horenshtein HadarCFO
EVice President of Finance Affairs, Chief Financial Officer & Secretary
Ilan Hadar M.B.A.CEO
Chairman & Chief Executive Officer
Total 3 executives

SLXN Frequently asked questions

What is Silexion Therapeutics Ltd. (SLXN) Stock Price?

Current stock price of Silexion Therapeutics Ltd. (SLXN) stock is $0.350. The stock price is -5.11% lower in the session. The intraday range can be seen from this page. Volume of Silexion Therapeutics Ltd. (SLXN) stock is 179.94K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Silexion Therapeutics Ltd. (SLXN) stock price going up or down today?

The stock price of Silexion Therapeutics Ltd. (SLXN) can change with earnings, company news, and overall market sentiment. Silexion Therapeutics Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Silexion Therapeutics Ltd. stock expensive at its current price?

Whether Silexion Therapeutics Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SLXN on this page is -0.01. EPS on this page is -39.55. Compare those figures with peers and growth expectations before deciding if the current Silexion Therapeutics Ltd. price is justified.

How has the stock price of Silexion Therapeutics Ltd. (SLXN) performed historically?

Historical performance for Silexion Therapeutics Ltd. (SLXN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SLXN reacted to past earnings and market events.

Should I buy Silexion Therapeutics Ltd. (SLXN) stock, at this price?

Buying Silexion Therapeutics Ltd. (SLXN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.